Drugs / Autologous dendritic cells transfected with amplified tumor RNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00006430 | — | prostate cancer | National Center for Research Resources (NCRR) | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous dendritic cells transfected with amplified tumor RNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006430 ↗ |
| Modality | Cell therapy | “cultured autologous peripheral blood precursor derived dendritic cells” NCT00006430 ↗ |
| Route | Intravenous | “combined I.V. and I.D. injections” NCT00006430 ↗ |